109048 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
INDUCIBLE EXPRESSION OF GENES IN ALGAE
#3902Antisense oligomers targeting PCSK9
#3903METHODS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE
#3904CMI SEQUENCES AS AN EARLY MARKER FOR THE FUTURE DEVELOPMENT OF CANCER, ATHEROSCLEROSIS, DIABETES AND DISEASES OF THE CNS AND AS A TARGET FOR THE TREATMENT AND PREVENTION OF THESE DISEASES
#3905OLIGOMER-CONJUGATE COMPLEXES AND THEIR USE
#3906RNA encoding a therapeutic protein
#3907BISPECIFIC ANTISENSE OLIGONUCLEOTIDES FOR DYSTROPHIN EXON SKIPPING
#3908NOVEL RNA COMPOSITIONS AND METHODS FOR INHIBITING ANGPTL8
#3909Compounds and methods for reducing prion expression
#3910System for producing cultivated meats, tissues and associated products from cells
#3911METHODS OF MODULATING RNA
#3912Ubiquitin-specific peptidase 24 inhibitor, medicinal composition including the same and method of delaying or reversing multidrug resistance in cancers using the same
#3913Saponin Conjugates
#3914Lipids and compositions for the delivery of therapeutics
#3915Use of IRE1α-XBP1 signaling pathway biomarkers for modulating immune responses
#3916COMPOSITION FOR PREDICTING CHEMOTHERAPY RESISTANCE OF OVARIAN CANCER AND USE THEREOF
#3917Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA
#3918RNAI STRATEGIES FOR CONTROL OF WHITEFLY
#3919ENGINEERED IMMUNOSTIMULATORY BACTERIAL STRAINS AND USES THEREOF
#3920Compositions and methods for treatment of Friedreich's Ataxia
#3921METHODS AND COMPOSITIONS FOR TREATING A SERPINC1-ASSOCIATED DISORDER
#3922EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
#3923METHODS OF CANCER TREATMENT
#3924NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF C3 IN A CELL
#3925OLIGONUCLEOTIDES CONJUGATES COMPRISING 7'-5'-ALPHA-ANOMERIC-BICYCLIC SUGAR NUCLEOSIDES
#3926GUIDE RNA FOR HSV-1 GENE EDITING AND METHOD THEREOF
#3927Genetically engineered t cells with regnase-1 and/or TGFBRII disruption have improved functionality and persistence
#3928NRF-2 DEFICIENT CELLS AND USES THEREOF
#3929RNAI MOLECULE FOR TREATING CANCER
#3930Composition for Inhibiting Replication of Hepatitis B Virus
#3931BIOLOGICALS AND THEIR USE IN PLANTS
#3932Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3933RNA AND DNA BASE EDITING VIA ENGINEERED ADAR RECRUITMENT
#3934Intron fragments
#3935AAV treatment of Huntington's disease
#3936ANGPTL4 oligonucleotides influencing the regulation of the fatty acid metabolism
#3937An lncRNA integrates a DNA-PK-mediated DNA damage response and vascular senescence
#3938Synthesis of modified oligonucleotides with increased stability
#3939COMPOSITIONS AND METHODS FOR CONTROLLING ARTHROPOD PARASITE AND PEST INFESTATIONS
#3940COMPOSITIONS AND METHODS FOR MODULATING TRANSCRIPTIONAL ACTIVITY OF AMPLIFIED ONCOGENES CONTAINED ON EXTRACHROMOSOMAL DNA
#3941METHODS OF TREATING NEURODEGENERATIVE DISORDERS AND IDENTIFYING TARGETS THEREFORE
#3942Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
#3943GENE THERAPIES FOR NEURODEGENERATIVE DISEASE
#3944Compositions and methods of treating muscle atrophy and myotonic dystrophy
#3945Animal model of mucopolysaccharidoses type IVA
#3946CELL LINES EXPRESSING INSERTED SECRETABLE REPORTER GENES AT MULTIPLE STAGES OF DIFFERENTIATION
#3947IDENTIFICATION OF JUND TARGET GENES FOR INHIBITION OF PROSTATE CANCER CELL GROWTH
#3948Acute kidney injury-specific biomarker, acute kidney injury diagnosis method, acute kidney injury test kit, animal treatment method and acute kidney injury medication
#3949RECOMBINANT YEAST CELL
#3950POLYNUCLEOTIDE AGENTS TARGETING AMINOLEVULINIC ACID SYNTHASE-1 (ALAS1) AND USES THEREOF
#3951COMPOUND AND METHOD FOR TREATING MYOTONIC DYSTROPHY
#3952MODIFIED DOUBLE-STRANDED RNA AGENTS
#3953METHODS OF SAFE ADMINISTRATION OF AN IRF5 ANTISENSE OLIGONUCLEOTIDE
#3954NUCLEIC ACID-GUIDED NUCLEASE OF NICKASE FUSION EDITING OF METHYLATED NUCLEOTIDES
#3955AMYLOID PRECURSOR PROTEIN (APP) RNAi AGENT COMPOSITIONS AND METHODS OF USE THEREOF
#3956METHODS FOR THE TREATMENT OF SMALL ROUND CELL TUMORS
#3957NUCLEIC ACIDS FOR INHIBITING EXPRESSION OF LPA IN A CELL
#3958Antisense RNA targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease
#3959COMPOSITIONS AND METHODS FOR CONTROLLING ARTHORPOD PARASITE AND PEST INFESTATIONS
#3960OLIGONUCLEOTIDE-MEDIATED SENSE CODON REASSIGNMENT
#3961CRISPR/CPF1 SYSTEMS AND METHODS
#3962METHODS AND COMPOSITIONS FOR KILLING A TARGET BACTERIUM
#3963Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation
#3964Methods of Treating Influenza A Virus Infections
#3965COMPOUNDS AND METHODS FOR MODULATING ANGIOTENSINOGEN EXPRESSION
#3966PROGNOSIS AND TREATMENT OF METASTATIC CANCER
#3967Lipid nanoparticle formulations
#3968CONTROL OF COLEOPTERAN INSECTS
#3969Methods and compositions for determining pH
#3970METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF
#3971Vector system for expressing regulatory RNA
#3972COPI COATOMER GAMMA SUBUNIT NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO COLEOPTERAN AND HEMIPTERAN PESTS
#3973Nucleic acids encoding CRISPR-associated proteins and uses thereof
#3974Specific siRNA molecules, composition and use thereof for the treatment of triple negative breast cancer
#3975COMPOSITIONS AND METHODS FOR CONTROLLING INSECT PESTS
#3976Control of insect infestation
#3977ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES
#3978Extended dicer substrate agents and methods for the specific inhibition of gene expression
#3979COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS D VIRUS INFECTION
#3980COMBINATION THERAPY FOR TREATMENT OF DISEASE
#3981Binding agents to pre-fusion state SARS-CoV-2 spike protein
#3982POLYNUCLEOTIDE AGENTS TARGETING HYDROXYACID OXIDASE (GLYCOLATE OXIDASE, HAO1) AND METHODS OF USE THEREOF
#3983OLIGONUCLEOTIDES TO TREAT EYE DISEASE
#3984Compositions and methods for organ specific delivery of nucleic acids
#3985PRIMARY CELL GENE EDITING
#3986Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors
#3987Antisense oligonucleotides that bind to exon 51 of human dystrophin pre-mRNA
#3988Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity
#3989SYNTHETIC OLIGONUCLEOTIDES HAVING REGIONS OF BLOCK AND CLUSTER MODIFICATIONS
#3990CONTROL OF INSECT INFESTATION
#3991METHOD FOR REDUCING THE RISK OF A CARDIOVASCULAR EVENT WITH CONJUGATED ANTISENSE COMPOUNDS TARGETING APO(A)
#3992RASOPATHY TREATMENT
#3993COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE
#3994COMPOSITIONS AND METHODS FOR MODULATING APOLIPOPROTEIN C-III EXPRESSION
#3995Monocarboxylate transporter (MCT) antisense oligonucleotide (ASO) inhibitors for use as therapeutics in the treatment of cancer
#3996TRANS-ACTIVATED FUNCTIONAL RNA BY STRAND DISPLACEMENT AND USES THEREOF
#3997Method and composition for inhibiting growth of bacterium
#3998Target-specific extracellular vesicles
#3999METHODS TO IMPROVE POTENCY OF ELECTROPORATION
#4000Compositions and methods for differentiation of human pluripotent stem cells into desired cell types
#4001Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
#4002MEDICAL DEVICES FOR DELIVERY OF siRNA
#4003Coordinating gene expression using RNA destabilizing elements
#4004Inhibition of expansion and function of pathogenic age-associated B cells and use for the prevention and treatment of autoimmune disease
#4005TREATMENTS FOR CHARCOT-MARIE-TOOTH DISEASE
#4006Compositions and methods for detection of SMN protein in a subject and treatment of a subject
#4007Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4008Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4009COMPOSITIONS AND METHODS FOR INHIBITION OF EXPRESSION OF PROTEIN C (PROC) GENES
#4010OLIGONUCLEOTIDE FORMULATION METHOD
#4011Extended dicer substrate agents and methods for the specific inhibition of gene expression
#4012Oligonucleotide agonists targeting progranulin
#4013MODIFIED DOUBLE STRANDED OLIGONUCLEOTIDE
#4014Dosages and methods for delivering lipid formulated nucleic acid molecules
#4015Methods of Manipulating the Fate of Cells
#4016Oligomers
#4017COMPOSITION FOR PREVENTING OR TREATING KELOIDS OR HYPERTROPHIC SCARS
#4018Gene-regulating compositions and methods for improved immunotherapy
#4019METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS USING RNA NANOPARTICLES FOR CELL TRANSFORMATION
#4020METHODS AND COMPOSITIONS FOR REGULATING IRON HOMEOSTASIS BY MODULATION OF BMP-6
#4021Phosphorothioate-conjugated miRNAs and methods of using the same
#4022ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#4023Temperature-based transient delivery of nucleic acids and proteins to cells and tissues
#4024Reducing Prominin2-Mediated Resistance to Ferroptotic Cell Death
#402517ß-Hydroxysteroid Dehydrogenase Type 13 (HSD17B13) iRNA Compositions And Methods Of Use Thereof
#4026Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases
#4027Anti-angiogenic miRNA therapeutics for inhibiting corneal neovascularization
#4028Methods and Compositions for the ADAR-Mediated Editing of SERPINA1
#4029MULTIMERIC OLIGONUCLEOTIDES HAVING DECREASED KIDNEY CLEARANCE
#4030The long non-coding RNA INCA1 and Homo sapiens heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) as therapeutic targets for immunotherapy
#4031Myocardial enhancer RNA and methods of use
#4032CHIRALLY ENRICHED OLIGOMERIC COMPOUNDS
#4033Complex comprising anti-transferrin receptor antibody covalently linked to an oligonucleotide that targets DUX4 RNA
#4034Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#4035Compositions And Methods For Treating Cancer
#4036TRANSCRIPTION FACTOR NtERF241 AND METHODS OF USING THE SAME
#4037METHOD AND MEANS TO DELIVER miRNA TO TARGET CELLS
#4038Multi-Targeting Nucleic Acid Constructs Composed Of Multiple Oligonucleotides That Modulate Gene Expression Through Complimentary Interactions With Targets
#4039OLIGONUCLEOTIDES FOR MODULATING MYH7 EXPRESSION
#4040COMPOSITIONS AND METHODS FOR DELIVERY OF AAV
#4041Nucleoside derivative and use thereof
#4042Method of delivering genes and drugs to a posterior segment of an eye
#4043Compositions and methods of treating Facioscapulohumeral muscular dystrophy
#4044METHODS OF TREATING MOTOR NEURON DISEASES
#4045METHODS, MODELS, SYSTEMS, AND APPARATUS FOR IDENTIFYING TARGET SEQUENCES FOR CAS ENZYMES FOR CRISPR-CAS SYSTEMS FOR TARGET SEQUENCES AND CONVEYING RESULTS THEREOF
#4046Vector-free intracellular delivery by reversible permeabilisation
#4047Compositions and therapeutic methods of microRNA gene delivery
#4048RNAi nano-preparation, preparation method thereof and application thereof in TMV prevention and control
#4049PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING MIR-324 and TUT4/7 EXPRESSION MODULATORS
#4050Use of Non-Coding Nucleic Acid for Crop Improvement and Protection Against Microbes
#4051SARNA COMPOSITIONS AND METHODS OF USE
#4052OLIGONUCLEOTIDES FOR SNCA MODULATION
#4053OLIGONUCLEOTIDES FOR MAPT MODULATION
#4054Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway
#4055Soluble TNF Receptors and Their Use in Treatment of Disease
#4056ENGINEERED AAV CAPSIDS WITH INCREASED TROPISM AND AAV VECTORS COMPRISING THE ENGINEERED CAPSIDS AND METHODS OF MAKING AND USING SAME
#4057P-ethoxy nucleic acids for liposomal formulation
#4058Compositions and methods for treating transthyretin (TTR) mediated amyloidosis
#4059CANNULA SYSTEM AND USE THEREOF
#4060BIOMARKERS AND METHODS FOR DIAGNOSIS OF EARLY STAGE PANCREATIC DUCTAL ADENOCARCINOMA
#4061ALTERNATIVE SPLICING REGULATION OF GENE EXPRESSION AND THERAPEUTIC METHODS
#4062METHODS TO ELIMINATE CANCER STEM CELLS BY TARGETING CD47
#4063METHODS AND COMPOSITIONS FOR EDITING RNAS
#4064OLIGONUCLEOTIDE MEDIATED NO-GO DECAY
#4065CARGO LOADED EXTRACELLULAR VESICLES
#4066OLIGONUCLEOTIDES FOR MSH3 MODULATION
#4067Sting-dependent activators for treatment of disease
#4068Treatment for NEAT1 associated disease
#4069METHODS AND COMPOSITIONS RELATING TO INHIBITING CARDIOVASCULAR CALCIFICATION VIA ANNEXIN A1
#4070Targeted replacement of endogenous T cell receptors
#4071MARKERS FOR PRE-CANCER AND CANCER CELLS AND THE METHOD TO INTERFERE WITH CELL PROLIFERATION THEREIN
#4072BARLEY STRIPE MOSAIC VIRUS-BASED GENE EDITING VECTOR SYSTEM
#4073IMMUNOTHERAPY OF CANCER
#4074Pig with a genetically modified CD163 gene resistant to PRRSv
#4075ENDOGENOUS CYTOPLASMIC ALU COMPLEMENTARY DNA IN AGE-RELATED MACULAR DEGENERATION
#4076The Microbiome as a Target of MicroRNAs for the Treatment of Disease
#4077Compositions and methods for inhibiting expression of the LECT2 gene
#4078NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION
#4079Substances for targeting various selected organs or tissues
#4080Synthetic lipid-like materials for brain delivery
#4081Lipid Vesicle for Oral Drug Delivery
#4082RNA targeting methods and compositions
#4083RNA targeting methods and compositions
#4084RNA targeting methods and compositions
#4085RNA targeting methods and compositions
#4086RNA targeting methods and compositions
#4087RNA targeting methods and compositions
#4088Bacterial biomarker
#4089Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4090Rapamycin resistant cells
#4091REGULATED GENE EDITING SYSTEM
#4092METHODS AND COMPOSITIONS TO INHIBIT METASTASIS AND TO TREAT FIBROSIS AND TO ENHANCE WOUND HEALING
#4093CHIMERIC DOUBLE-STRANDED NUCLEIC ACID
#4094Modified AAV constructs and uses thereof
#4095Compositions and methods for prevention of bladder fibrosis
#4096AN RNA G-QUADRUPLEX STRUCTURE IN PRE-miRNA-1229 AS A THERAPEUTIC TARGET FOR ALZHEIMER'S DISEASE AND VARIOUS CANCERS
#40972' FANA MODIFIED FOXP3 ANTISENSE OLIGONUCLEOTIDES AND METHODS OF USE THEREOF
#4098Dual-acting siRNA based modulation of C9orf72
#4099Mixed Tricyclo-DNA, 2'-Modified RNA Oligonucleotide Compositions and Uses Thereof
#4100Oligonucleotides for tissue specific gene expression modulation
#4101Thermostable Cas9 nucleases
#4102USE OF NEGATIVE FUNCTIONAL MODULATORS OF ERYTHROPOIETIN FOR THERAPY
#4103Use of regulatory T cell-specific surface protein LRIG-1
#4104ANTISENSE NUCLEIC ACIDS
#4105THERAPEUTIC EXOSOMES AND METHOD OF PRODUCING THEM
#4106METHODS FOR PREVENTING AND TREATING PULMONARY INFLAMMATION AND FIBROSIS
#4107Method for preparing liposomes
#4108Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4109Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4110Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells using microcarriers
#4111GENE THERAPIES FOR LYSOSOMAL DISORDERS
#4112COMPOSITIONS AND METHODS FOR IMMUNE CHECKPOINT INHIBITION
#4113MINIATURIZED HAIRPIN RNAi TRIGGERS (mxRNA) AND METHODS OF USES THEREOF
#4114Protecting RNAs from degradation using engineered viral RNAs
#4115Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery
#4116RNAI INDUCED C9ORF72 SUPPRESSION FOR THE TREATMENT OF ALS/FTD
#4117Compositions containing nucleic acid nanoparticles with modular functionality
#4118Induce and enhance immune responses using recombinant replicon systems
#4119Delivery across cell plasma membranes
#4120AAV VECTORS FOR TREATMENT OF DOMINANT RETINITIS PIGMENTOSA
#4121MicroRNA and inhibitors thereof and methods of treatment
#4122Mad nucleases
#4123METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING T CELL-DRIVEN DISEASES
#4124MODULATING IMMUNE RESPONSES
#4125Polycationic methyl phospholipids for improved delivery of nucleic acids to eukaryotic cells
#4126MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA
#4127Sequence specific antimicrobials
#4128BENZIMIDAZOLES THAT ENHANCE THE ACTIVITY OF OLIGONUCLEOTIDES
#4129siRNA nanocapsule and preparation method and use thereof
#4130COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS
#4131Method of producing hairpin single-stranded RNA molecules
#4132RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS
#4133POLYNUCLEOTIDE AGENTS TARGETING PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) AND METHODS OF USE THEREOF
#4134CANCER STEM CELL MARKER AND CANCER STEM CELL TARGETING DRUG
#4135SERPINA1 iRNA compositions and methods of use thereof
#4136Compositions and methods for modulating neuronal excitability and motor behavior
#4137MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
#4138Positional delivery and encoding by oligonucleotides of biological cells for single cell sequencing (POS SEQ)
#4139GENE TARGETS FOR T-CELL-BASED IMMUNOTHERAPY
#4140NR2F6 INHIBITED CHIMERIC ANTIGEN RECEPTOR CELLS
#4141COMPOSITIONS AND METHODS FOR DRUG DELIVERY AND TREATING VIRAL INFECTIONS
#4142Compounds and Methods for Modulation of Transcript Processing
#4143MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
#4144Method for diagnosis, prognosis and determination of treatment for cutaneous t-cell lymphoma
#4145METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#4146Nitrogen responsive transcription factors in plants
#4147Curing for recursive nucleic acid-guided cell editing
#4148CATIONIC COMPOUNDS FOR DELIVERY OF NUCLEIC ACIDS
#4149RNA-BASED THERAPEUTIC METHODS TO PROTECT ANIMALS AGAINST PATHOGENIC BACTERIA AND / OR PROMOTE BENEFICIAL EFFECTS OF SYMBIOTIC AND COMMENSAL BACTERIA
#4150COMPOUNDS OF CHEMICALLY MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE THEREOF
#4151VARIANT RNAi AGAINST ALPHA-SYNUCLEIN
#4152Therapeutic and diagnostic target for SARS-CoV-2 and COVID-19
#4153MODIFIED PEPTIDE NUCLEIC ACID COMPOSITIONS
#4154Antisense oligomers for treatment of conditions and diseases
#4155Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders
#4156COMBINATION THERAPY FOR SPINAL MUSCULAR ATROPHY
#4157MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FRIEDREICH'S ATAXIA
#4158MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES
#4159Compositions of Asymmetric Interfering RNA and Uses Thereof
#4160Compositions and methods of treating Facioscapulohumeral muscular dystrophy
#4161METHODS OF TREATING OSMIDROSIS
#4162Methods for improving resistance to soybean rust
#4163Methods for controlling meristem size for crop improvement
#4164Mad nucleases
#4165METHODS OF TREATING ACUTE RESPIRATORY DISTRESS SYNDROME
#4166HUMAN iPSC-DERIVED BRAIN ORGANOIDS AND USES THEREOF
#4167COMPLEX CAPABLE OF INHIBITING GENETIC FUNCTION IN EXOSOME, AND CANCER PROLIFERATION AND/OR METASTASIS SUPPRESSOR
#4168CELL-PENETRATING PEPTIDES
#4169Cell-penetrating peptides
#4170Compositions and methods for targeted RNA delivery
#4171Selective inhibition of T Follicular Helper cells for treatment of autoimmune disorders
#4172CO-DELIVERY OF NUCLEIC ACIDS FOR SIMULTANEOUS SUPPRESSION AND EXPRESSION OF TARGET GENES
#4173Aerosol-generating device for the inhalation administration of an antisense-molecule-containing composition
#4174METHODS OF ACTIVATING DYSFUNCTIONAL IMMUNE CELLS AND TREATMENT OF CANCER
#4175ENGINEERED INCOHERENT FEED FORWARD LOOP AND USES THEREOF
#4176CHO CELL LINE, CONSTRUCTION THEREOF AND RECOMBINANT PROTEIN EXPRESSION SYSTEM USING CHO CELL LINE
#4177Iterative genome editing in microbes
#4178Methods and compositions for directed genome editing
#4179HIF 1-alpha antisense oligonucleotides
#4180COMPOSITIONS COMPRISING INTERMEDIATE NON-CODING RNA REGULATORS MODULATING THE EXPRESSION OF ETV6 OR FOXO1 AND USES THEREOF
#4181COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES AND USES THEREOF
#4182Exosomes and miRNA to treat glaucoma
#4183Extended dicer substrate agents and methods for the specific inhibition of gene expression
#4184Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
#4185NOVEL DOUBLE-STRANDED OLIGONUCLEOTIDES FOR THE TREATMENT OF CANCER
#4186Methods and compositions for directed genome editing
#4187CANCER TARGETS AND USES THEREOF
#4188Transcriptome in vivo analysis (TIVA) and transcriptome in situ analysis (TISA)
#4189Peptidic blocks for nucleic acid delivery
#4190Trimeric peptides for antisense delivery
#4191TREATMENT OF DISEASE BASED ON IMMUNE CELL SEQUENCING
#4192METHODS AND COMPOSITIONS FOR MODULATING CELLULAR AGING
#4193Coordinating Gene Expression Using RNA Destabilizing Elements
#4194ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#4195MODULATION OF LNC05 EXPRESSION
#4196Methods of treating PACS1 and PACS2 syndromes
#4197GFI1 INHIBITORS FOR THE TREATMENT OF HYPERGLYCEMIA
#4198METHODS AND COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH CORTICO-HIPPOCAMPAL HYPERACTIVITY
#4199METHODS OF SUPPRESSING DELIVERY OF EXOSOMES TO LIVER AND SPLEEN
#4200WPRE mutant constructs, compositions, and methods thereof